Respiratory Diseases

The objective of this Project Licence is to identify and evaluate novel chemicals that could provide new medicines for asthma (which affects 53 million patients worldwide) or chronic obstructive pulmonary disease (the sixth most common cause of death worldwide).

Date: Wed Nov 30 15:59:19 GMT 2005